Alon Nahshony

Since joining IMBM, Alon has been working on a new dynamical model for hormone sensitive prostate cancer, based on clinical data obtained from the Mayo Clinic at Rochester, USA. The ultimate aim of this project is to develop an algorithm for predicting when a patient under hormone therapy will become resistant to this drug.